findmyKOL

Neil Gheewala, MD

Basic profile

Tucson Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionTucson, AZ · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Neil Gheewala is a Cardiology physician affiliated with Tucson Medical Center. OpenAlex indexes 21 publications with 990 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex.

990citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
31companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4729 E Camp Lowell Dr
Tucson, AZ 857121256

Telephone

520-321-4800

Provider last certified this registry record 6 May 2021.

View the NPPES registry record

Industry payments

31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.9%
    Beta blocker20.7%
    Metoprolol Succinate51%Metoprolol Tartrate27%Carvedilol19%Atenolol4%
    Part D<11 patients
    Statin16.7%
    Atorvastatin Calcium78%Rosuvastatin Calcium16%Pravastatin Sodium4%Simvastatin3%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    16.2%
    Factor Xa inhibitor9.1%
    Eliquis79%Xarelto21%
    Part D≥80 patients
    P2Y12 inhibitor5.5%
    Clopidogrel82%Brilinta12%Prasugrel Hcl7%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    4.1%
    Potassium supplement2%
    Potassium Chloride100%
    Part D≥30 patients
    SGLT2 inhibitor1.6%
    Jardiance81%Farxiga19%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)23.2% facility · 76.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”